Evidence map›Paper›PMID 42198630›Full record

ArticlePathogens (Basel, Switzerland)2026

Prevalence of

Yasmina Drissi-El Boukili, Eduard Rovira-Vallbona, Pieter Guetens, Driss Chiheb, Johanna Helena Kattenberg, Luc Kestens, Sonia Maria Mauricio Enosse, Anna Rosanas-Urgell, Paulo Arnaldo

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yasmina Drissi-El BoukiliDepartment of Biomedical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium.ORCID 0000-0002-7390-097X
Eduard Rovira-VallbonaDepartment of Biomedical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium.ORCID 0000-0002-4765-1076
Pieter GuetensDepartment of Biomedical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium.
Driss ChihebDepartment of Biomedical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium.
Johanna Helena KattenbergDepartment of Biomedical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium.
Luc KestensDepartment of Biomedical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium.
Sonia Maria Mauricio EnosseDivisão de Investigação em Saúde e Bem-Estar, Instituto Nacional de Saúde, Maputo 264, Mozambique.
Anna Rosanas-UrgellDepartment of Biomedical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium.
Paulo ArnaldoDepartment of Biomedical Sciences, Institute of Tropical Medicine, 2000 Antwerp, Belgium.ORCID 0000-0001-8747-5209

Funding

Directorate-General for International Cooperation and Development FA4/5Institute of Tropical Medicine Antwerp Malariology UnitResearch Foundation - Flanders PhD fellowship strategic basic research (1S74321N)Vlaamse Interuniversitaire Raad BICMINS project
6 · The paper itself

Abstract

Intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) remains the main strategy to prevent malaria in pregnancy. However, continued drug pressure may also contribute to the emergence of resistant parasites and impact the gametocyte carriage and subsequent infectiousness. Pregnant women are thought to be a potential reservoir for malaria transmission due to the increased carriage of gametocytes following long-lasting infections. We used molecular methods to examine 100

Indexed as

AntimalarialsDihydropteroate SynthaseDrug ResistanceMalaria, FalciparumPlasmodium falciparumPyrimethamineSulfadoxineTetrahydrofolate DehydrogenaseAdultDrug CombinationsFemaleHaplotypesHumansMozambiqueMutationPolymorphism, GeneticAntimalarialsDHFR protein, Plasmodium falciparumDihydropteroate SynthaseDrug Combinationsfanasil, pyrimethamine drug combinationProtozoan ProteinsPyrimethamineSulfadoxineTetrahydrofolate Dehydrogenasegametocyte carriageintermittent preventive treatmentmalaria in pregnancymalaria transmissionMozambiquequintuple mutant haplotypesextuple mutant haplotypesulfadoxine-pyrimethamine resistance

Identifiers

PMID42198630
PMCPMC13209286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.